Benefits of Drinking Clear Fluids Until Called to the Operating Room in Adult Surgical Patients (HYDRATE)

May 20, 2025 updated by: Wuerzburg University Hospital

A Pilot Study to Test Benefits of Drinking Clear Fluids Until Called to the Operating Room in Adult Surgical Patients

The purpose of this study is to show if - compared to standard practice - allowing adults undergoing surgical procedures under anaesthesia care to drink clear fluids up to a volume of 200 ml between 2 h prior to the operation and the call to operation room (approximately 30 min prior to anaesthesia induction) will decrease patient thirst and increase patient satisfaction.

Study Overview

Study Type

Interventional

Enrollment (Actual)

174

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bavaria
      • Würzburg, Bavaria, Germany, 97080
        • Wuerzburg University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Adult patients (≥ 18 years)
  2. American Society of Anesthesiologists (ASA) physical status classification I-III
  3. Undergoing surgical procedure under anaesthesia care: general anaesthesia, regional anaesthesia, combined anaesthesia or monitored anaesthesia care.

The proportion of Patients undergoing general or combined anaesthesia is aimed to exceed 75%

Exclusion Criteria:

  1. Absolute indication for rapid sequence induction including but not limited to:

    1. Bowel obstruction including ileus
    2. Stricture and oesophageal disorders including achalasia
    3. Recent polytrauma or trauma of the upper gastrointestinal tract
    4. Acute abdomen/peritonitis including active gastrointestinal bleeding
  2. Relative indication for (modified) rapid sequence induction includes, but is not limited to:

    1. Symptomatic gastroesophageal reflux disease, independent of food intake and persistent under medical treatment (PPI)
    2. Hiatus hernia or upside down stomach
    3. Upper gastrointestinal tumour
    4. History of upper gastrointestinal surgery (oesophageal, gastric, duodenum, pancreatic)
    5. Medically confirmed gastroparesis
    6. Severe obesity, defined as body mass index ≥ 40 kg/m2
  3. Dysphagia
  4. Renal replacement therapy
  5. Fluid restriction therapy
  6. Pregnancy
  7. Expected need for postoperative mechanical ventilation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual care
Fasting instructions as given by anaesthesiologist according to national guidelines (6 h solid meal and thick liquids, 2 h clear fluids).
Active Comparator: Instructed guideline adherence
Patients should not involuntarily fast fluids for longer than 2 h.
OP-schedule is closely monitored and patients will be visited to support and encourage them in drinking clear fluids.
Experimental: Experimental intervention
Patients should not involuntarily fast fluids for longer than 30 min.
OP-schedule is closely monitored and patients will be visited to support and encourage them in drinking clear fluids.
Patients may drink up to 200 ml clear fluids between 2 h prior to the surgery and the call to operation room.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thirst
Time Frame: Prior to induction of anaesthesia
At any stage after your hospital admission have you had the following: Thirst (No/ Yes, moderate/ Yes, severe)
Prior to induction of anaesthesia

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total number of protocol deviations per group
Time Frame: From enrollment until last Follow-up is concluded at up to 48 hours post surgery
Outcome assessment successfully blinded Real fluid fasting time is less than allocated fluid fasting time
From enrollment until last Follow-up is concluded at up to 48 hours post surgery
Fluid fasting time
Time Frame: Prior to induction of anesthesia
Actual fluid fasting time in hours
Prior to induction of anesthesia
RASS
Time Frame: 2 hours after end of surgery
Richmond Agitation Sedation Scale. A scale from -5 to +4 is used. Negative values indicate a sedated state. Positive values indicate an agitated state.
2 hours after end of surgery
CAM-ICU
Time Frame: 2 hours after end of surgery
Confusion Assessment Method for the Intensive Care Unit.
2 hours after end of surgery
Headache
Time Frame: Prior to induction of anesthesia and 2 hours after end of surgery
At any stage after your hospital admission have you had the following: Headache (No/ Yes, moderate/ Yes, severe)
Prior to induction of anesthesia and 2 hours after end of surgery
Change of systolic blood pressure on induction of anesthesia
Time Frame: 5 minutes prior and 15 minutes after induction of anesthesia
The difference between the highest value before induction of anesthesia and the lowest value after induction of anesthesia will be reported.
5 minutes prior and 15 minutes after induction of anesthesia
Change of diastolic blood pressure on induction of anesthesia
Time Frame: 5 minutes prior and 15 minutes after induction of anesthesia
The difference between the highest value before induction of anesthesia and the lowest value after induction of anesthesia will be reported.
5 minutes prior and 15 minutes after induction of anesthesia
Change of mean arterial pressure on induction of anesthesia
Time Frame: 5 minutes prior and 15 minutes after induction of anesthesia
The difference between the highest value before induction of anesthesia and the lowest value after induction of anesthesia will be reported.
5 minutes prior and 15 minutes after induction of anesthesia
Vasopressor
Time Frame: Within 15 minutes after induction of anesthesia
Use of Vasopressors
Within 15 minutes after induction of anesthesia
Blood glucose level
Time Frame: At induction of anesthesia (Values assessed within 15 minutes prior and 15 minutes after induction of anesthesia will be accepted)
Blood glucose level
At induction of anesthesia (Values assessed within 15 minutes prior and 15 minutes after induction of anesthesia will be accepted)
Intravenous catheter placement
Time Frame: Between admission to the operation room and induction of anesthesia
Number of attempts for placing a (first) peripheral intravenous catheter (only applicable if a peripheral intravenous catheter needs to be placed)
Between admission to the operation room and induction of anesthesia
Postoperative nausea and vomiting
Time Frame: 2 hours after end of surgery
Postoperative nausea and vomiting is a composite endpoint of the following dimensions: Vomiting, retching, nausea, and/or use of rescue medication.
2 hours after end of surgery
Unplanned ICU/IMC
Time Frame: From end of surgery until last Follow-up is concluded at up to 48 hours post surgery
Unplanned intensive/intermediate care unit stay due to respiratory complications
From end of surgery until last Follow-up is concluded at up to 48 hours post surgery
Number of Participants with confirmed bronchopulmonary aspiration
Time Frame: From induction of anesthesia until last Follow-up is concluded at up to 48 hours post surgery
If relevant bronchopulmonary aspiration is suspected, it needs to be confirmed by bronchoscopy or radiology imaging up to 48 hours after anaesthesia procedure
From induction of anesthesia until last Follow-up is concluded at up to 48 hours post surgery
All cause mortality
Time Frame: From end of surgery until last Follow-up is concluded at up to 48 hours post surgery
Death within observation period
From end of surgery until last Follow-up is concluded at up to 48 hours post surgery
Change of heart rate on induction of anesthesia
Time Frame: 5 minutes prior and 15 minutes after induction of anesthesia
The difference between the highest value before induction of anesthesia and the lowest value after induction of anesthesia will be reported.
5 minutes prior and 15 minutes after induction of anesthesia
Patient satisfaction
Time Frame: 2 hours after end of surgery
Patient satisfaction, operationalized using the Bauer Satisfaction Questionnaire, includes 10 ordinal items with 3 levels (where higher values indicate unfavourable outcomes), 5 items on a Likert scale with 4 levels (where lower values indicate unfavourable outcomes), and one binary item.
2 hours after end of surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Patrick Meybohm, Prof. Dr., University Hospital Würzburg, Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Oberdürrbacher Str. 6, 97080 Würzburg, Germany
  • Principal Investigator: Tobias E Haas, Dr., University Hospital Würzburg, Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Oberdürrbacher Str. 6, 97080 Würzburg, Germany

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 24, 2024

Primary Completion (Actual)

November 4, 2024

Study Completion (Actual)

November 4, 2024

Study Registration Dates

First Submitted

January 5, 2024

First Submitted That Met QC Criteria

February 9, 2024

First Posted (Actual)

February 12, 2024

Study Record Updates

Last Update Posted (Actual)

May 25, 2025

Last Update Submitted That Met QC Criteria

May 20, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia

Clinical Trials on Additional pre-OP-visit

Subscribe